This combo delivers complementary GH-axis research tools in one order. CJC-1295 (no DAC)—also known as Mod GRF 1-29—is a 29-amino-acid GHRH analog with four substitutions that improve DPP-IV resistance while preserving a short, pulsatile half-life. Ipamorelin is a pentapeptide selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Researchers combine these compounds to study synergistic pituitary signaling: CJC-1295 stimulates GHRH receptors on somatotrophs, while ipamorelin activates ghrelin receptors. Parallel assay designs allow direct comparison of pulsatile vs. sustained GH release patterns. Each combo includes one 10 mg vial of CJC-1295 (no DAC) and one 10 mg vial of Ipamorelin. Both are >99.6% pure and ship with individual CoAs. FAQ What is CJC-1295 Ipamorelin combo used for? Researchers study this combination in models of growth hormone secretion, ghrelin receptor signaling, and IGF-1 pathway activation to compare pulsatile vs. acute GH axis stimulation. Where can I buy CJC-1295 and Ipamorelin for research? You can buy the CJC-1295 + Ipamorelin research combo from Haelo Labs. Both peptides are third-party tested, USA-made, and ship with full Certificates of Analysis. Why is ipamorelin called a "clean" GHRP? Ipamorelin selectively activates GHS-R1a with minimal effect on cortisol, prolactin, or aldosterone—unlike non-selective GHRPs—making it ideal for isolating GH-specific research effects.
Research Use Only
This product is intended for laboratory research purposes only. Not for human consumption or clinical use.
